2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 34.235 | 59.652 | 64.742 | 58.346 | 56.020 | 47.524 | 48.945 | 44.545 | 48.886 | - |
Total Income - EUR | 34.235 | 59.652 | 64.742 | 58.565 | 56.020 | 47.524 | 48.945 | 44.545 | 48.886 | - |
Total Expenses - EUR | 29.098 | 56.126 | 56.846 | 52.105 | 57.964 | 50.094 | 47.402 | 45.128 | 46.173 | - |
Gross Profit/Loss - EUR | 5.137 | 3.526 | 7.896 | 6.460 | -1.944 | -2.570 | 1.543 | -583 | 2.713 | - |
Net Profit/Loss - EUR | 746 | 2.955 | 6.703 | 5.874 | -2.506 | -3.042 | 1.053 | -986 | 1.465 | - |
Employees | 1 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | - |
Check the financial reports for the company - Farmacompet S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 2.731 | 272 | 0 | 1.491 | 1.655 | 1.623 | 1.592 | 1.557 | 0 | - |
Current Assets | 15.647 | 18.960 | 18.214 | 16.968 | 16.773 | 21.221 | 12.301 | 10.694 | 4.148 | - |
Inventories | 10.104 | 8.504 | 10.028 | 6.957 | 7.047 | 5.906 | 6.381 | 6.263 | 0 | - |
Receivables | 4.706 | 4.499 | 4.860 | 5.278 | 4.577 | 12.651 | 3.710 | 2.302 | 1.405 | - |
Cash | 836 | 5.956 | 3.325 | 4.733 | 5.149 | 2.664 | 2.209 | 2.129 | 2.743 | - |
Shareholders Funds | 10.422 | 16.101 | 6.830 | 12.588 | 9.851 | 6.619 | 3.453 | 2.390 | 3.863 | - |
Social Capital | 45 | 45 | 45 | 44 | 43 | 0 | 41 | 40 | 41 | - |
Debts | 7.955 | 3.131 | 11.384 | 5.871 | 8.577 | 16.225 | 10.441 | 9.861 | 285 | - |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7500 - 7500" | |||||||||
CAEN Financial Year |
7500
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Farmacompet S.r.l.